Nose cartilage used to fix knees in new trial
NCT ID NCT06163573
First seen Mar 24, 2026 · Last updated Jun 23, 2026 · Updated 14 times
Summary
This Phase II trial tests whether an implant made from a patient's own nasal cartilage can repair knee damage from patellofemoral osteoarthritis. 75 adults aged 18–65 with moderate knee pain will receive either the cartilage implant or standard platelet-rich plasma injections. The main goal is to see if the implant improves knee pain and function over two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PATELLOFEMORAL OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Crossklinik
RECRUITINGBasel, 4054, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hôpitaux universitaires de Genève
RECRUITINGGeneva, 1205, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Orthopädische Klinik König-Ludwig-Haus
NOT_YET_RECRUITINGWürzburg, 97074, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Ospedale Regionale di Lugano
RECRUITINGLugano, 6962, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Poliklinika Ivković
RECRUITINGZagreb, 10000, Croatia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Poliklinika Ortho Plus
RECRUITINGZagreb, 10000, Croatia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Sportclinic, Klinik Hirslanden
RECRUITINGZurich, 8032, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Basel
RECRUITINGBasel, 4031, Switzerland
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Freiburg
NOT_YET_RECRUITINGFreiburg im Breisgau, 79106, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
nasal cartilage graft (N-TEC) or platelet-rich plasma (PRP) injections
What this could lead to
If successful, this could offer a new way to repair knee cartilage and reduce pain from osteoarthritis, potentially delaying or avoiding joint replacement.
What could go wrong
This is an early Phase II trial with only 75 participants, so results may not apply to everyone. The procedure is surgical and carries risks like infection or graft failure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.